10x Genomics Commercially Launches Visium HD Spatial Gene Expression Assay
26 Mar 2024
Gene Therapy
Began global shipments for Visium HD, a new product that enables whole transcriptome spatial discovery at single cell–scale resolution
PLEASANTON, Calif., March 26, 2024 /PRNewswire/ -- 10x Genomics, Inc. (Nasdaq: TXG), a leader in single cell and spatial biology, announced today the commercial availability of its Visium HD Spatial Gene Expression product. This assay enables researchers to measure the whole transcriptome from FFPE tissue sections at single cell-scale resolution.
Preview
Source: PRNewswire
A side-by-side comparison of Visium data (left) and Visium HD data (right) in FFPE human colorectal cancer, demonstrating the discovery power of whole transcriptome spatial gene expression at single cell–scale resolution.
For more details,please visit the original website
The content of the article does not represent any opinions of Synapse and its affiliated companies. If there is any copyright infringement or error, please contact us, and we will deal with it within 24 hours.
Organizations
Indications
Targets
-Drugs
-Hot reports
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Leverages most recent intelligence information, enabling fullest potential.